美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

HORIZON KINETICS MEDICAL ETF

34.62

-0.6385-1.81%

成交量：236

成交额：8,215

市值：1,626.76万

市盈率：- -

高：34.68

开：34.68

低：34.62

收：35.25

52周最高：37.90

52周最低：30.79

股本：46.99万

流通股本：46.99万

量比：0.79

换手率：0.05%

股息：0.41

股息率：1.18%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

施贵宝（BMY）骨髓瘤新药3期试验成功可显著降低疾病进展死亡风险

核心产品海外三期研究失败艾力斯20cm跌停还带崩了创新药板块？

核心产品海外三期研究失败艾力斯20cm跌停还带崩了创新药板块？

东方财富网

众生药业(002317.SZ)：一类创新药RAY1225注射液减重III期临床试验获得顶线分析数据结果

东方海洋：子公司取得医疗器械注册证

东方海洋(002086.SZ)：水溶性维生素测定试剂盒(液相色谱-串联质谱法)取得医疗器械注册证

九强生物(300406.SZ)：5款产品取得医疗器械注册证书

核心产品海外关键Ⅲ期临床未达主要终点，400亿创新药企跌停

东方财富网

法国制药股金菲特、纳米生物科技与瓦尔内瓦股价跌幅在4.8%至6.2%之间。

营收猛增42%且扭亏为盈! 人工椎间盘领军者Centinel Spine冲刺美股IPO 创新医疗器械迎估值检验

港股异动 | 创新药概念股午后跌幅扩大歌礼制药-B(01672)跌超10% 信达生物(01801)跌近4%

创新药大跌点评

每日经济新闻

一品红(300723.SZ)子公司创新药APH04935片获得美国FDA临床试验批准

美国FDA扩大诺华一款用于治疗慢性皮肤病的药物适应症

创业板盘中跌超1%，科创50跌2%，光芯片、创新药大跌，海运、覆铜板拉升，恒科指跌超1%，AI大模型双雄集体下挫

华尔街见闻

创新药板块高开低走，艾力斯20cm跌停

国家卫健委等两部门：将疗效确切、群众急需的康复护理类医疗服务项目纳入基本医疗保险支付范围

礼来(LLY)股票10月7日盘中上涨3.94%：真相来了

TradingKey中文

制药行业游说团体就“医疗保险”药品降价问题起诉特朗普政府

诺华Rhapsido®获FDA批准成为首款症状性皮肤划痕症治疗药物

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/MEDX/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.6159,"timestamp":1791921600000,"preClose":35.2544,"halted":0,"volume":236,"delay":0,"changeRate":-0.018111214486702183,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"未开盘","change":-0.6385,"latestTime":"10-13 16:00:00 EDT","open":34.675,"high":34.675,"low":34.6159,"amount":8215,"amplitude":0.001676,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":35.2544,"sharesOutstanding":569946,"nav":35.25,"aum":16565596.5,"dividendRate":0.011838,"bidAskSpread":0,"volumeRatio":0.794078},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.794078,"shares":469946,"dividePrice":0.4098,"high":34.675,"amplitude":0.001676,"preClose":35.2544,"low":34.6159,"week52Low":30.79,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.6159,"eps":0,"divideRate":0.011838,"volume":236,"delay":0,"ttmEps":0,"open":34.675,"prevYearClose":33.2024,"prevWeekClose":35.2935,"prevMonthClose":35.2817,"prevQuarterClose":35.2817,"fiveDayClose":34.7275,"twentyDayClose":34.9577,"sixtyDayClose":34.7445},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673870070","title":"施贵宝（BMY）骨髓瘤新药3期试验成功 可显著降低疾病进展死亡风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2673870070","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673870070?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 20:49","pubTimestamp":1791463785,"startTime":"0","endTime":"0","summary":"金吾财讯 | 施贵宝 周四公布，包含Zenbexus的联合疗法在3期EXCALIBER-RRMM临床试验中取得积极顶线结果。Zenbexus是一款针对罕见血液癌症多发性骨髓瘤的药物，已于今年8月获美国FDA加速批准上市，获批依据为微小残留病灶阴性完全缓解这一双主要终点指标。研究达成对比标准治疗的双主要终点无进展生存期：Zenbexus联合治疗组中位无进展生存期42个月，标准治疗组为20个月；中位随访23个月条件下，该联合方案将患者疾病进展或死亡风险降低51%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306986","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","JDOC","LU0203347892.USD","LU1261432733.SGD","LU2236285917.USD","RXL","VHT","MEDX","LU2347655156.SGD","BMED","GDOC","LU0234570918.USD","LU0683600562.USD","LU0994945656.USD","IXJ","LU2089984988.USD","TRUH","FTXH","LU0070217475.USD","PJP","BK4532","LU2468319806.SGD","LU0306807586.USD","IE00BVYPNV92.GBP","LU0949170772.SGD","SG9999013999.USD","LU1670710588.SGD","IE00B1BXHZ80.USD","LU0237698245.USD","LU2129689431.USD","XLV","BK4504","LU1894683264.USD","IHE","LU0545562505.USD","LU0882574055.USD","LU0069063385.USD","IE00B4R5TH58.HKD","LU1032466523.USD","LU1983299246.USD","LU1121112475.USD","LU0072461881.USD","FHLC","LU1244550577.SGD","LU1571399168.USD","BMY","IYH","JNJ","LU1868837136.USD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074940","title":"核心产品海外三期研究失败 艾力斯20cm跌停 还带崩了创新药板块？","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074940","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074940?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 19:59","pubTimestamp":1791460744,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673741340","title":"核心产品海外三期研究失败 艾力斯20cm跌停 还带崩了创新药板块？","url":"https://stock-news.laohu8.com/highlight/detail?id=2673741340","media":"东方财富网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673741340?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 19:51","pubTimestamp":1791460260,"startTime":"0","endTime":"0","summary":"【核心产品海外三期研究失败 艾力斯20cm跌停 还带崩了创新药板块？】10月8日，A股多家药企股价下跌明显。具体来看，艾力斯20%跌停，丽珠集团10%跌停，亚虹医药跌超11%，益方生物、百奥泰、三生国健等跌超7%。业内普遍认为，此次创新药板块集体下挫的导火索是国内创新药企艾力斯的三期临床试验失败的负面消息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202610083889811123.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202610083889811123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["06978","688578","BK0239","BK1574","159992","IBBQ","LNGR","MEDX","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673071276","title":"众生药业(002317.SZ)：一类创新药RAY1225注射液减重III期临床试验获得顶线分析数据结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2673071276","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673071276?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 19:35","pubTimestamp":1791459349,"startTime":"0","endTime":"0","summary":"智通财经APP讯，众生药业 发布公告，公司控股子公司广东众生睿创生物科技有限公司自主研发的一类创新多肽药物RAY1225注射液在超重或肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验，于近日获得顶线分析数据。REBUILDING-2临床试验于近日完成数据清理和锁定，获得顶线分析结果，达到主要终点。RAY1225注射液在主要有效性指标以及多种心血管和代谢危险因素改善等多个关键次要有效指标均显著优于安慰剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504817.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","LNGR","BK0077","BMED","IBBQ","BK1161","06978","159992","BK1574","002317","BK0239","MDTX","IBBJ","PSYK","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673027468","title":"东方海洋：子公司取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2673027468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673027468?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 16:55","pubTimestamp":1791449710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","MEDX","MDEV","LNGR","HART","LGHT","RSPH","GDOC","AGNG","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673002765","title":"东方海洋(002086.SZ)：水溶性维生素测定试剂盒(液相色谱-串联质谱法)取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2673002765","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673002765?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 16:43","pubTimestamp":1791449027,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司子公司质谱生物科技有限公司自主研发的水溶性维生素测定试剂盒(液相色谱-串联质谱法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。上述产品获准上市，进一步丰富了质谱生物科技有限公司在临床检测领域的产品线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","BK1574","LNGR","002086","IEIH","MEDX","09996","LGHT","GDOC","MDEV","PTH","BK1583","HART","BK0046","BK0092","159883","BK0213","BK1100","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022610","title":"九强生物(300406.SZ)：5款产品取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022610","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022610?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 16:23","pubTimestamp":1791447834,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司及全资子公司北京美创新跃医疗器械有限公司(以下简称“美创新跃”)于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，涉及产品：“天门冬氨酸氨基转移酶测定试剂盒(天门冬氨酸底物法)”、“总免疫球蛋白 E测定试剂盒(磁微粒化学发光免疫分析法)”、“抑制素B测定试剂盒(磁微粒化学发光免疫分析法)”、“碱性磷酸酶测定试剂盒(NPP 底物-AMP缓冲液法)”、“凝血酶时间检测试剂盒(凝固法)”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","BK0046","BK1583","PTH","BK0077","IEIH","BK1100","RSPH","BK0028","AGNG","BK1574","HART","MDEV","300406","LGHT","09996","LNGR","BK0012","159883","BK0239","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673024930","title":"核心产品海外关键Ⅲ期临床未达主要终点，400亿创新药企跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2673024930","media":"东方财富网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673024930?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 15:51","pubTimestamp":1791445875,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明10月8日，艾力斯（688578.SH）以92.83元/股开盘后20cm跌停，报89.26元/股，对应总市值401.67亿元。对比年内137.54元/股的高点，回撤达35.1%。利空源于一纸临床公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202610083889616077.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202610083889616077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["06978","BK1161","LNGR","MEDX","159992","BK1574","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673029609","title":"法国制药股金菲特、纳米生物科技与瓦尔内瓦股价跌幅在4.8%至6.2%之间。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673029609","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673029609?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 15:10","pubTimestamp":1791443426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4585","LNGR","MEDX","XBI","IEIH","SYNB","AGNG","IBBJ","GDOC","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673293026","title":"营收猛增42%且扭亏为盈! 人工椎间盘领军者Centinel Spine冲刺美股IPO 创新医疗器械迎估值检验","url":"https://stock-news.laohu8.com/highlight/detail?id=2673293026","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673293026?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 14:44","pubTimestamp":1791441889,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国知名医疗器械制造商Centinel Spine当地时间周三在提交的美国股市首次公开募股申报文件中披露，上半年营收大幅增长42%。Centinel Spine此次递交IPO申请，可谓为全球聚焦于医疗器械的投资者们提供了一个“技术商业化、收入增长与盈利改善同步加速推进”的观察样本。目前该公司尚未完成IPO发行与最终的估值定价。Centinel Spine计划将此次发行募集的资金用于偿还债务，并投资于销售基础设施、患者宣传教育项目、临床试验等方面。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LGHT","AGNG","PTH","REDS","MEDX","HART","FRHC","IEIH","LNGR","GDOC","09996","KCE","IPOS","159883","MDEV","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673230400","title":"港股异动 | 创新药概念股午后跌幅扩大 歌礼制药-B(01672)跌超10% 信达生物(01801)跌近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673230400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673230400?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 14:01","pubTimestamp":1791439309,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，创新药概念股午后跌幅扩大，截至发稿，歌礼制药-B跌9.82%，报7.62港元；诺诚健华跌6.37%，报12.65港元；三生制药跌4.20%，报15.04港元；信达生物跌3.90%，报93.7港元。消息面上，俄罗斯伊尔库茨克州疑似鼠疫病毒感染事件近期引发国际关注。世卫组织发言人林德迈尔10月6日表示，根据目前掌握的信息，世卫组织初步风险评估认为，伊尔库茨克地区的风险为“中等至低”，俄罗斯联邦整体风险为“低”，世卫组织欧洲区域的风险为“非常低”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LNGR","01801","LU2097828557.USD","BK1589","LU0455707207.USD","LU1188198961.HKD","01530","KURE","LU2328871848.SGD","HK0000165453.HKD","BK1583","LU0149534421.HKD","MEDX","BK1191","VXUS","IBBQ","LU0607220059.USD","LU2242644610.SGD","LU2097828805.USD","LU2097828631.EUR","LU2097828474.EUR","LU1969619763.USD","LU0244354667.USD","BK4588","LU0502904849.HKD","06978","KCAI","LU2097828714.EUR","01477","LU2488822045.USD","BK4585","LU0326950275.SGD","01672","159992","BK1574","LU1831875114.USD","BK1515","BK1161","BK1593","LU0463099449.HKD","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673028773","title":"创新药大跌点评","url":"https://stock-news.laohu8.com/highlight/detail?id=2673028773","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673028773?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 13:12","pubTimestamp":1791436360,"startTime":"0","endTime":"0","summary":"今日早盘医药板块领跌，科创创新药ETF（589720）跟踪指数盘中一度跌超5%。【下跌原因】1、科创新药指数权重股出现临床失败事件。据报道，伏美替尼一线治疗非小细胞肺癌EGFR20外显子插入突变全球III期临床失败，未能达到主要终点PFS。其合作方美股上市的ArriVent当晚大跌近60%。2、国庆长假期间，港股创新药板块表现较好，部分资金借此事件有短线兑现需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202610083889466625.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202610083889466625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","IBBQ","MEDX","BK1574","159992","BK1161","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673477770","title":"一品红(300723.SZ)子公司创新药APH04935片获得美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2673477770","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673477770?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 11:52","pubTimestamp":1791431539,"startTime":"0","endTime":"0","summary":"智通财经APP讯，一品红(300723.SZ)发布公告，近日，公司全资子公司广州一品红制药有限公司(简称“一品红制药”)收到美国食品药品监督管理局(FDA)下发的关于同意公司子公司自主研发的创新药物APH04935片临床试验的函。APH04935 片是由公司自主研发的一种高活性、高选择性的小分子GLP-1R(全称：Glucagon-like Peptide-1 Receptor，中文译为：胰高血糖素样肽-1 受体)激动剂，目标成为一款一天给药一次的口服小分子 GLP-1R 激动剂，拟用于控制体重及长期减重管理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159992","300723","BK1574","06978","IBBQ","LNGR","MEDX","BK0239","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673136042","title":"美国FDA扩大诺华一款用于治疗慢性皮肤病的药物适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2673136042","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673136042?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 10:52","pubTimestamp":1791427935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B4R5TH58.HKD","LU0211331839.USD","MEDX","NVS","IE00BJT1NW94.SGD","LU0070302665.USD","BK4588","LABU","LU0208291251.USD","BK4532","PPH","IE0002141913.USD","IE00B2B36J28.USD","BK4007","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4578","BK4585","IE00BJJMRZ35.SGD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673042878","title":"创业板盘中跌超1%，科创50跌2%，光芯片、创新药大跌，海运、覆铜板拉升，恒科指跌超1%，AI大模型双雄集体下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2673042878","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673042878?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 10:34","pubTimestamp":1791426843,"startTime":"0","endTime":"0","summary":"早盘PCB概念再度活跃，世名科技、东材科技涨停，同宇新材、呈和科技涨超10%，方邦股份、南亚新材、圣泉集团等跟跌。东山精密、源杰科技双双跌停，光芯片指数下滑超4%。消息称，当前光芯片价格已经承压，1.6T配套光芯片存在降价压力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3783152","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","LNGR","AIPO","LRNZ","PSI","QTOC","159915","07226","159992","SOXS","BOAT","399006","USD","SOXX","CHAT","AGIX","EPAI","159813","IBBQ","FTXL","MEDX","SMH","XSD","VTHR","SOXY","06978","159967","399300","CNXT","SOXQ","KSTR","WISE","SMHX","CHPS","510300","GPTZ","399001","510880","ARTY","TEKX","512880","000905.SH","SSG","515890","SOXL","000300.SH","512510","000688.SH","000001.SH","CHPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673041240","title":"创新药板块高开低走，艾力斯20cm跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2673041240","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673041240?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 09:39","pubTimestamp":1791423553,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673041129","title":"国家卫健委等两部门：将疗效确切、群众急需的康复护理类医疗服务项目纳入基本医疗保险支付范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2673041129","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673041129?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 09:27","pubTimestamp":1791422824,"startTime":"0","endTime":"0","summary":"金吾财讯 | 10月8日消息，国家卫健委、国家发改委印发《医疗康复护理扩容提升工程实施方案》。其中提到，完善多元支付体系。按程序将疗效确切、群众急需的康复护理类医疗服务项目纳入基本医疗保险支付范围。推进医保支付方式改革，完善特例单议等配套机制，对接受康复护理服务的短期住院患者实行按病种付费，对接受康复护理服务的长期住院患者探索实行按床日付费等支付方式。鼓励商业保险公司开发康复护理相关保险产品，并与基本医疗保险、长期护理保险、工伤保险做好衔接。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/N2FhZjdlNDZjNGUyMzE4MDgzODIzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/N2FhZjdlNDZjNGUyMzE4MDgzODIzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993271","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011454","title":"礼来(LLY)股票10月7日盘中上涨3.94%：真相来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011454","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011454?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 00:16","pubTimestamp":1791389770,"startTime":"0","endTime":"0","summary":"• 礼来全年营收达 651.8 亿美元，净利润为 206.4 亿美元。\n• 强劲的减重药研发管线以及药物 Mounjaro 和 Zepbound 提振了投资者信心。\n• 华尔街分析师对其长期前景保持积极看法，并维持“买入”评级。","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262204369-market-movers-lly-20261007","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","ELIL","LU1623119135.USD","SGXZ57979304.SGD","LU1917777945.USD","LU2552382132.HKD","LU0133085943.USD","LU2491050154.USD","LU0354030438.USD","LU1868836914.USD","LU2602419157.SGD","WDNA","SGXZ81514606.USD","LU1548497426.USD","LU0353189680.USD","LU0203202063.USD","SGXZ99366536.SGD","LU0006306889.USD","LU1551013425.SGD","LU1989771016.USD","LU2491049909.HKD","THNR","IE0002141913.USD","IE00BN29S564.USD","LU0256863811.USD","IE00BFSS7M15.SGD","LU1974910355.USD","LU1093756325.SGD","LU0345770308.USD","LU2106854487.HKD","SG9999014914.USD","LU0320765992.SGD","LU0708995401.HKD","SG9999017495.SGD","LU0943347566.SGD","LU2063271972.USD","LU1093756168.USD","SG9999015986.USD","LU2211815571.USD","LU1983299246.USD","LU2168563687.JPY","ELIS","LU0353189763.USD","LU2168564065.EUR","LU2756315664.SGD","LU0820561818.USD","RXL","LU0097036916.USD","FHLC","LU1267930730.SGD","IE00B2B36J28.USD","IE00BK4W5M84.HKD","BK4516","LU2357305700.SGD","IE00BJJMRZ35.SGD","IE00B7KXQ091.USD","GDOC","LU0256863902.USD","MHIP","LU0316494557.USD","IE00BKDWB100.SGD","LU2746668974.SGD","IE00B4JS1V06.HKD","LU0889565916.HKD","SG9999014898.SGD","LU2265009873.SGD","LU0225283273.USD","LU0640476718.USD","LU2471134952.CNY","LU0323591593.USD","LU1720051108.HKD","IE00BJLML261.HKD","XLV","LU0964807845.USD","LU1127390331.HKD","LU0210536198.USD","SG9999015952.SGD","LU0094547139.USD","IE0009355771.USD","LU2746668461.USD","LU2461242641.AUD","IE0005OL40V9.USD","LU0820561909.HKD","LLYX","LU1868837136.USD","LU2750360997.AUD","IE00BKPKM429.USD","LU2087625088.SGD","HRTS","MEDI","LU2471134879.HKD","SG9999018865.SGD","LU0109391861.USD","IE00BK4W5L77.USD","LU0471298694.HKD","PPH","VHT","LU1280957306.USD","LU0456855351.SGD","LU1551013342.USD","LU1691799644.USD","LU0158827781.USD","IYH","LU2361044865.SGD","IE00B1BXHZ80.USD","LU0345770993.USD","LU0683600562.USD","LU1145028129.USD","SG9999014906.USD","LU2456880835.USD","SG9999001176.SGD","LU0058720904.USD","JDOC","IE00BJJMRY28.SGD","LU0689472784.USD","LU0061475181.USD","MEDX","LU0174119429.USD","BK4581","LU2361044949.HKD","LU2168564495.EUR","BK4534","LU2462591350.SGD","LU2324357040.USD","LU2111349929.HKD","SG9999013999.USD","LU1366192091.USD","LU2089283258.USD","SG9999014880.SGD","LU0158827948.USD","LU1035775433.USD","LU0234572021.USD","LU0096364046.USD","LU1804176565.USD","LU0385154629.USD","LU2491050071.SGD","LU2237443382.USD","LU2896262040.SGD","LU2471134796.USD","LU2417539215.USD","LU0786609619.USD","LU0823416689.USD","SGXZ51526630.SGD","LU2237443465.HKD","LU1814569148.SGD","LU1868836757.USD","LU2271345857.HKD","LU0672654240.SGD","ILDR","BK4585","LU2237443978.SGD","LU2462157665.USD","LU2360106947.USD","LU1868836591.USD","BK4533","LU2552382215.SGD","LU0109394709.USD","LU0823434583.USD","BK4599","IE00B775H168.HKD","IE00BFSS8Q28.SGD","FTXH","IE0004445015.USD","LU0289739699.SGD","GB00BDT5M118.USD","LU1291159041.SGD","LU1720051017.SGD","TRUH","LU0417517546.SGD","CURE","IE00B1XK9C88.USD","LU2237443895.HKD","LU0882574055.USD","IE00B4R5TH58.HKD","LU2237443622.USD","OZEM","TMED","CANC","LU2471134523.USD","LU1988902786.USD","LLYZ","LU1064131342.USD","BK4007","LU1023059063.AUD","LU2236285917.USD","LU2168564222.USD","IXJ","LU0432979614.USD","IHE","LU1061106388.HKD","LU2023250504.SGD","LU0203201768.USD","LU1323610961.USD","SG9999018857.SGD","LU0466842654.USD","LU0471298777.SGD","LU2237438978.USD","LU1069344957.HKD","LU0122379950.USD","LU2552382058.USD","LU2750360641.GBP","IE0004445239.USD","LU2089284900.SGD","LU1979441026.SGD","BK4588","LU2468319806.SGD","AGNG","IE0001KFT4U8.USD","IE00BJT1NW94.SGD","PJP","LU2264538146.SGD","LU1712237335.SGD","LU0114720955.EUR","LU0238689110.USD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2023251221.USD","LU2108987350.USD","LU2028103732.USD","LU2112291526.USD","LLY","SG9999015978.USD","LU1057294990.SGD","LU0882574139.USD","IE00BJJMRX11.SGD","LU2361045086.USD","LU2089984988.USD","LU0079474960.USD","LU1629891620.HKD","LU0266013472.USD","LU0354030511.USD","LU1232071149.USD","SG9999015945.SGD","LLII","SG9999001176.USD","LU2213496289.HKD","LU2237443549.SGD","LU0198837287.USD","LU0823434740.USD","LU0820562030.AUD","LU0320765059.SGD","LU2168564149.EUR","SGXZ31699556.SGD","LU2756315318.SGD","LU2023250330.USD","LU0787776722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673801115","title":"制药行业游说团体就“医疗保险”药品降价问题起诉特朗普政府","url":"https://stock-news.laohu8.com/highlight/detail?id=2673801115","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673801115?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 00:11","pubTimestamp":1791389462,"startTime":"0","endTime":"0","summary":"《GLOBE规则》旨在为“联邦医疗保险”患者设定医院药品价格。该规则的最终版本于上周发布，详细规定了如何将基于一组可比国家支付标准的“最惠国”定价体系纳入“联邦医疗保险B部分”计划。该游说团体在诉状中辩称，作为“医疗保险”监管机构的CMS，已将一项用于测试新定价方案的计划的权限扩大到重写“医疗保险”的定价结构，而未经过国会批准。美国卫生与公众服务部尚未就该诉讼立即作出回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nL4S45T188:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030438.USD","LU0964807845.USD","JDOC","LU0882574139.USD","TRUH","FHLC","LLY","LLYX","VHT","GDOC","ELIS","IHE","LU2552382215.SGD","CURE","LU1035775433.USD","ILDR","LU0820561818.USD","MEDI","OZEM","PJP","LLYZ","THNR","LLII","LU1623119135.USD","HRTS","LU2756315318.SGD","PPH","LU1868836591.USD","LU1066051498.USD","MEDX","IE00BFSS7M15.SGD","CANC","LU2063271972.USD","IXJ","BK4533","LU0345770308.USD","FTXH","IYH","TMED","WDNA","PFE","LU0158827781.USD","XLV","IE00BJJMRY28.SGD","ELIL","AGNG","RXL","MHIP","LU2324357040.USD","LU2361044949.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011362","title":"诺华Rhapsido®获FDA批准 成为首款症状性皮肤划痕症治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011362?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 23:54","pubTimestamp":1791388472,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","MEDX","BK4585","LU0211331839.USD","IE00B2B36J28.USD","BK4007","BK4588","BK4578","PPH","BK4532","NVS","LU0208291251.USD","IE0009355771.USD","IE0002141913.USD","LABU","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}